Effects of Short-term Estrogen Treatment on the Progression of N-methyl-N-nitrosourea-induced Premalignant Mammary Lesions in Female Lewis Rats

Overview

Journal Med Mol Morphol

Publisher Springer

Specialties Cell Biology
Molecular Biology
Pathology

Date 2011 Sep 17

PMID 21922383

Citations 2

Authors

Takashi Yuri

Yen-Chang Lai

Sayaka Kanematsu

Maki Kuwata

Katsuhiko Yoshizawa

Airo Tsubura

Affiliations

Soon will be listed here.

Abstract

We studied the effects of short-term estrogen treatment (STET) on the progression of mammary lesions from ductal hyperplasia (DH) through ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) in the N-methyl-N-nitrosourea (MNU)-induced rat mammary carcinogenesis model. Three-week-old female Lewis rats (n = 40) received an intraperitoneal injection of MNU (50 mg/kg). Three weeks later, a 3-week-release, 0.25-mg, 17β-estradiol pellet was subcutaneously implanted for 2 weeks in 20 rats (STET); the remaining 20 rats did not receive the estradiol pellets (age-matched control). All rats were killed at 12 weeks of age, and their abdominal-inguinal mammary glands were histologically examined. The incidence and multiplicity of DHs were similar between groups (STET, 90% and 3.9 ± 0.6 vs. age-matched controls, 80% and 3.0 ± 0.5). However, DCIS and IDC did not develop in STET rats, whereas DCIS (25% and 1.4 ± 0.2) and IDC (35% and 1.4 ± 0.3) developed in the age-matched controls. Immunoscores of estrogen and progesterone receptors and positive rate of proliferative cell nuclear antigen (PCNA) in DH were similar in both groups, while the positive rate of cyclin D1 was significantly reduced in the STET group (P < 0.05). Thus, STET blocked the progression from DH to DCIS in MNU-induced mammary carcinogenesis, and decreased expression of cyclin D1 may play an important role in the blockade of cell transition from DH to DCIS.

Citing Articles

Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype.

Sun X, Nichols H, Tse C, Bell M, Robinson W, Sherman M Cancer Epidemiol Biomarkers Prev. 2015; 25(1):60-7.

PMID: 26545404 PMC: 4727837. DOI: 10.1158/1055-9965.EPI-15-0864.

Histopathological and immunohistochemical characterization of spontaneously occurring uterine deciduomas in young adult rats.

Yoshizawa K, Emoto Y, Kinoshita Y, Kimura A, Uehara N, Yuri T J Toxicol Pathol. 2013; 26(1):61-6.

PMID: 23723570 PMC: 3620216. DOI: 10.1293/tox.26.61.

References

Tsubura A, Yoshizawa K, Uehara N, Yuri T, Matsuoka Y . Multistep mouse mammary tumorigenesis through pre-neoplasia to neoplasia and acquisition of metastatic potential. Med Mol Morphol. 2007; 40(1):9-17. DOI: 10.1007/s00795-006-0351-6. View

Rajkumar L, Guzman R, Yang J, Thordarson G, Talamantes F, Nandi S . Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci U S A. 2001; 98(20):11755-9. PMC: 58802. DOI: 10.1073/pnas.201393798. View

Rajkumar L, Kittrell F, Guzman R, Brown P, Nandi S, Medina D . Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models. Breast Cancer Res. 2007; 9(1):R12. PMC: 1851398. DOI: 10.1186/bcr1645. View

Thompson H, McGinley J, Wolfe P, Singh M, Steele V, Kelloff G . Temporal sequence of mammary intraductal proliferations, ductal carcinomas in situ and adenocarcinomas induced by 1-methyl-1-nitrosourea in rats. Carcinogenesis. 1999; 19(12):2181-5. DOI: 10.1093/carcin/19.12.2181. View

Thompson H, McGinley J, Rothhammer K, Singh M . Ovarian hormone dependence of pre-malignant and malignant mammary gland lesions induced in pre-pubertal rats by 1-methyl-1-nitrosourea. Carcinogenesis. 1998; 19(3):383-6. DOI: 10.1093/carcin/19.3.383. View

Wang T, Cardiff R, Zukerberg L, Lees E, Arnold A, SCHMIDT E . Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 1994; 369(6482):669-71. DOI: 10.1038/369669a0. View

Silvera S, Rohan T . Benign proliferative epithelial disorders of the breast: a review of the epidemiologic evidence. Breast Cancer Res Treat. 2007; 110(3):397-409. DOI: 10.1007/s10549-007-9740-3. View

Isaacs J . Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res. 1986; 46(8):3958-63. View

Krishnamurthy S, Sneige N . Molecular and biologic markers of premalignant lesions of human breast. Adv Anat Pathol. 2002; 9(3):185-97. DOI: 10.1097/00125480-200205000-00002. View

10.

Sgambato A, Han E, Zhang Y, Moon R, Santella R, Weinstein I . Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors. Carcinogenesis. 1995; 16(9):2193-8. DOI: 10.1093/carcin/16.9.2193. View

11.

Moriya T, Kasajima A, Ishida K, Kariya Y, Akahira J, Endoh M . New trends of immunohistochemistry for making differential diagnosis of breast lesions. Med Mol Morphol. 2006; 39(1):8-13. DOI: 10.1007/s00795-006-0309-8. View

12.

Yang J, Yoshizawa K, Nandi S, Tsubura A . Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats. Carcinogenesis. 1999; 20(4):623-8. DOI: 10.1093/carcin/20.4.623. View

13.

Huggins C, Moon R, Morii S . Extinction of experimental mammary cancer. I. Estradiol-17beta and progesterone. Proc Natl Acad Sci U S A. 1962; 48:379-86. PMC: 220788. DOI: 10.1073/pnas.48.3.379. View

14.

Tsubura A, Uehara N, Matsuoka Y, Yoshizawa K, Yuri T . Estrogen and progesterone treatment mimicking pregnancy for protection from breast cancer. In Vivo. 2008; 22(2):191-201. View

15.

Hunter T, Pines J . Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell. 1994; 79(4):573-82. DOI: 10.1016/0092-8674(94)90543-6. View

16.

Fitzgibbons P, Page D, Weaver D, Thor A, Allred D, Clark G . Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000; 124(7):966-78. DOI: 10.5858/2000-124-0966-PFIBC. View

17.

Thompson H, Singh M, McGinley J . Classification of premalignant and malignant lesions developing in the rat mammary gland after injection of sexually immature rats with 1-methyl-1-nitrosourea. J Mammary Gland Biol Neoplasia. 2001; 5(2):201-10. DOI: 10.1023/a:1026495322596. View

18.

Sivaraman L, Hilsenbeck S, Zhong L, Gay J, Conneely O, Medina D . Early exposure of the rat mammary gland to estrogen and progesterone blocks co-localization of estrogen receptor expression and proliferation. J Endocrinol. 2001; 171(1):75-83. DOI: 10.1677/joe.0.1710075. View

19.

Dong Y, Asch H, Medina D, Ip C, Ip M, Guzman R . Concurrent deregulation of gelsolin and cyclin D1 in the majority of human and rodent breast cancers. Int J Cancer. 1999; 81(6):930-8. DOI: 10.1002/(sici)1097-0215(19990611)81:6<930::aid-ijc15>3.0.co;2-a. View

20.

Zhu X, Hartwick W, Rohan T, Kandel R . Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma. Mod Pathol. 1998; 11(11):1082-8. View